The management of Vera Salus Ricerca Srl (VSR) has decided unanimously to continue FlavOncology’s development in Switzerland, recognizing the fertile...
Month: December 2020
7 December 20207 December 2020
Vera Salus Ricerca has successfully completed a 1-year training at BioArk (Switzerland) aimed at polishing the business developmental plans of FlavOncology, its proprietary drug platform for the cure of cancer patients.
During 2020, Vera Salus Ricerca Srl (VSR) has performed a Pre-incubation Program at BioArk (Valais, Switzerland) sponsored by the Ark...